As venture-backed life sciences companies grapple with an evolving and difficult regulatory, business and financing environment, innovative companies and their investors are challenging the old models for building and financing a life sciences company and exploring whether there is a better way to achieve their goals.

Moving from a C-corporation structure to an LLC holding company structure is one alternative that is being increasingly considered, but one size does not fit all. Companies and their investors need to consider whether the potential tax benefits from adopting such a structure are likely to be realized given the companies’ assets and whether those potential benefits outweigh the costs of implementing and maintaining such a structure.

In this webinar, partners from WilmerHale's Corporate and Tax Practices discussed the LLC holding company structure, its potential benefits and drawbacks, and, for existing C-corporations, timing and financial considerations for implementing such a move.

View the Webinar Recording
View the Presentation Slides

Please contact Andrea Burke for more information.